121 related articles for article (PubMed ID: 10556676)
21. Ibogaine and the dopaminergic response to nicotine.
Maisonneuve IM; Mann GL; Deibel CR; Glick SD
Psychopharmacology (Berl); 1997 Feb; 129(3):249-56. PubMed ID: 9084063
[TBL] [Abstract][Full Text] [Related]
22. Dose- and time-dependent, context-induced elevation of dopamine and its metabolites in the nucleus accumbens of morphine-induced CPP rats.
Ma YY; Meng L; Guo CY; Han JS; Lee DY; Cui CL
Behav Brain Res; 2009 Dec; 204(1):192-9. PubMed ID: 19539657
[TBL] [Abstract][Full Text] [Related]
23. 18-Methoxycoronaridine acts in the medial habenula to attenuate behavioral and neurochemical sensitization to nicotine.
Eggan BL; McCallum SE
Behav Brain Res; 2016 Jul; 307():186-93. PubMed ID: 27059333
[TBL] [Abstract][Full Text] [Related]
24. Attenuation of morphine withdrawal signs by intracerebral administration of 18-methoxycoronaridine.
Panchal V; Taraschenko OD; Maisonneuve IM; Glick SD
Eur J Pharmacol; 2005 Nov; 525(1-3):98-104. PubMed ID: 16289028
[TBL] [Abstract][Full Text] [Related]
25. Ghrelin receptor antagonism of morphine-induced accumbens dopamine release and behavioral stimulation in rats.
Sustkova-Fiserova M; Jerabek P; Havlickova T; Kacer P; Krsiak M
Psychopharmacology (Berl); 2014 Jul; 231(14):2899-908. PubMed ID: 24531567
[TBL] [Abstract][Full Text] [Related]
26. Nociceptin differentially affects morphine-induced dopamine release from the nucleus accumbens and nucleus caudate in rats.
Di Giannuario A; Pieretti S
Peptides; 2000 Jul; 21(7):1125-30. PubMed ID: 10998547
[TBL] [Abstract][Full Text] [Related]
27. Differential effects of ibogaine on behavioural and dopamine sensitization to cocaine.
Szumlinski KK; Maisonneuve IM; Glick SD
Eur J Pharmacol; 2000 Jun; 398(2):259-62. PubMed ID: 10854838
[TBL] [Abstract][Full Text] [Related]
28. Neuropharmacological characterization of local ibogaine effects on dopamine release.
Reid MS; Hsu K; Souza KH; Broderick PA; Berger SP
J Neural Transm (Vienna); 1996; 103(8-9):967-85. PubMed ID: 9013390
[TBL] [Abstract][Full Text] [Related]
29. Mechanisms of antiaddictive actions of ibogaine.
Glick SD; Maisonneuve IS
Ann N Y Acad Sci; 1998 May; 844():214-26. PubMed ID: 9668680
[TBL] [Abstract][Full Text] [Related]
30. Co-administration of dextromethorphan with morphine attenuates morphine rewarding effect and related dopamine releases at the nucleus accumbens.
Huang EY; Liu TC; Tao PL
Naunyn Schmiedebergs Arch Pharmacol; 2003 Nov; 368(5):386-92. PubMed ID: 14564449
[TBL] [Abstract][Full Text] [Related]
31. Biphasic dose-related effects of morphine on dopamine release.
Maisonneuve IM; Warner LM; Glick SD
Drug Alcohol Depend; 2001 Dec; 65(1):55-63. PubMed ID: 11714590
[TBL] [Abstract][Full Text] [Related]
32. Nicotine and heroin augment cocaine-induced dopamine overflow in nucleus accumbens.
Zernig G; O'Laughlin IA; Fibiger HC
Eur J Pharmacol; 1997 Oct; 337(1):1-10. PubMed ID: 9389374
[TBL] [Abstract][Full Text] [Related]
33. Ascorbate reduces morphine-induced extracellular DOPAC level in the nucleus accumbens: A microdialysis study in rats.
Rajaei Z; Alaei H; Nasimi A; Amini H; Ahmadiani A
Brain Res; 2005 Aug; 1053(1-2):62-6. PubMed ID: 16051201
[TBL] [Abstract][Full Text] [Related]
34. Neurochemical predisposition to self-administer morphine in rats.
Glick SD; Merski C; Steindorf S; Wang S; Keller RW; Carlson JN
Brain Res; 1992 Apr; 578(1-2):215-20. PubMed ID: 1380861
[TBL] [Abstract][Full Text] [Related]
35. Differential impact of pavlovian drug conditioned stimuli on in vivo dopamine transmission in the rat accumbens shell and core and in the prefrontal cortex.
Bassareo V; De Luca MA; Di Chiara G
Psychopharmacology (Berl); 2007 Apr; 191(3):689-703. PubMed ID: 17072592
[TBL] [Abstract][Full Text] [Related]
36. Differential behavioural sensitization to intermittent morphine treatment in alcohol-preferring AA and alcohol-avoiding ANA rats: role of mesolimbic dopamine.
Ojanen S; Koistinen M; Bäckström P; Kankaanpää A; Tuomainen P; Hyytiä P; Kiianmaa K
Eur J Neurosci; 2003 Apr; 17(8):1655-63. PubMed ID: 12752383
[TBL] [Abstract][Full Text] [Related]
37. Acute and prolonged effects of ibogaine on brain dopamine metabolism and morphine-induced locomotor activity in rats.
Maisonneuve IM; Rossman KL; Keller RW; Glick SD
Brain Res; 1992 Mar; 575(1):69-73. PubMed ID: 1504783
[TBL] [Abstract][Full Text] [Related]
38. In heterozygous GDNF knockout mice the response of striatal dopaminergic system to acute morphine is altered.
Airavaara M; Mijatovic J; Vihavainen T; Piepponen TP; Saarma M; Ahtee L
Synapse; 2006 May; 59(6):321-9. PubMed ID: 16437537
[TBL] [Abstract][Full Text] [Related]
39. Sex differences in ibogaine antagonism of morphine-induced locomotor activity and in ibogaine brain levels and metabolism.
Pearl SM; Hough LB; Boyd DL; Glick SD
Pharmacol Biochem Behav; 1997 Aug; 57(4):809-15. PubMed ID: 9259010
[TBL] [Abstract][Full Text] [Related]
40. 18-MC reduces methamphetamine and nicotine self-administration in rats.
Glick SD; Maisonneuve IM; Dickinson HA
Neuroreport; 2000 Jun; 11(9):2013-5. PubMed ID: 10884062
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
